Thank you, Seth, and thank you for joining us, everyone. Q4 and Fiscal 2024 results. Revenue for the fourth quarter and the full-year 2024 was $114.2 million and $428.8 million, a year-over-year increase of 1.9% for the quarter and a decrease of 0.6% for the full-year. Client revenue for the fourth quarter and full-year 2024 within the United States represented 47% and 49%, while international clients represented 53% and 51%, respectively. Our fourth quarter revenue was positively impacted by slightly over $5 million due to a onetime client event that brought forward the remaining revenue into the quarter. Annualized recurring revenue was $414.8 million for the fourth quarter, a year-over-year decrease of 4.1%. Revenue retention rate for service subscriptions, which makes up 96% of our revenue, was 88%, with approximately 88% of subscription revenue noncancelable for at least 12 months. We note that for the full-year 2024, FX movements negatively impacted our total revenues by 1.3%, compared to a negative impact of 0.6% for 2023. Billings for the fourth quarter were $172.1 million, up 7.1% year-over-year, and full-year 2024 billings were $423 million, an increase of 1.1%. In the fourth quarter, billings, excluding PeopleSoft-associated billings, increased 12% on a year-over-year basis. Gross margin was 63.7% of revenue for the fourth quarter and 60.9% for full-year 2024, compared to 61% of revenue for the prior year fourth quarter and 62.3% for prior year 2023. On a non-GAAP basis, which excludes stock-based compensation expense, gross margin was 64% of revenue for the fourth quarter and 61.3% for full-year 2024, compared to 61.5% of revenue for the prior year fourth quarter and 62.8% for prior year 2023. We do note, however, that the aforementioned onetime revenue benefit did contribute to our strong gross margin during the quarter. Nonetheless, excluding this onetime favorable event, we are pleased with this result of our continued focus on driving operational leverage through improved systems, processes and global staffing models, while continuing to deliver best-in-class support for a wider array of support, optimization and transformational offerings. Despite our methodical focus on gross margin improvement opportunities through efficiency, we will continue to balance gross margin improvement against investment needs to take advantage of new revenue growth opportunities and initiatives such as our nascent services for VMware and ServiceNow. Operating expenses. As noted in our previous earnings calls, we initiated a cost optimization plan to reduce our net operating costs by $35 million on an annual basis, measured from Q1 quarter-end 2024 to Q1 quarter-end 2025. As of Q4, the net cost reduction on an annualized basis was $18 million. The variance to the reported trend is associated with onetime project-related spend in the second half of the year. At the midpoint of the current quarter, Q1 of 2025, our net annualized cost reductions totaled $22 million. While this plan was appropriate at the time it was initiated, we are evaluating this broader initiative in the current quarter to ensure we are properly investing in the growth opportunities as Seth outlined earlier. Reorganization charges associated with the cost optimization plan for the fourth quarter was $1.1 million and for 2024 was $5.7 million. We do expect to incur additional reorganization costs during 2025 as we continue to optimize our cost structure in areas where opportunities to streamline our operations exist. Sales and marketing expenses as a percentage of revenue was 32.8% of revenue for the fourth quarter and 34.9% for the full-year 2024, compared to 31.2% of revenue for the prior year fourth quarter and 33% for prior year 2023. On a non-GAAP basis, which excludes stock-based compensation expense, sales and marketing expenses as a percentage of revenue was 32.2% of revenue for the fourth quarter and 34.4% for the full-year 2024, compared to 30.5% of revenue for the prior year fourth quarter and 32.3% for prior year 2023. General and administrative expenses as a percentage of revenue, excluding outside litigation costs, was 16.3% of revenue for the fourth quarter and 17% for full-year 2024, compared to 15.7% of revenue for the prior year fourth quarter and 16.9% for prior year 2023. On a non-GAAP basis, which excludes stock-based compensation expense and litigation costs, G&A was 15.1% of revenue for the fourth quarter and 15.7% for full-year 2024, compared to 13.8% of revenue for the prior year fourth quarter and 15.1% for prior year 2023. Outside litigation cost was $675,000 for the fourth quarter and $6.1 million for the full-year 2024, compared to $1.6 million for the prior year fourth quarter and $7 million for prior year 2023. Litigation settlement expense was $58.5 million for full-year 2024, compared to $2.7 million for prior year 2023. As Seth addressed earlier, there was a litigation payment of $58.5 million in the fourth quarter that represented the court-ordered reimbursement to Oracle for their attorney's fees and costs related to the Rimini II case. This expense, however, was accrued during the third fiscal quarter of 2024. For full-year 2025, we expect outside litigation expense to remain consistent with non-trial periods, where full-year spend approaches $10 million. Net income attributable to shareholders for the fourth quarter was $6.7 million, or $0.07 per diluted share, compared to the prior year fourth quarter net income of $0.10 per diluted share. Full-year 2024 net loss was $0.40 per diluted share, compared to net income of $0.29 per diluted share for prior year 2023. On a non-GAAP basis, net income for the fourth quarter was $10.8 million, or $0.12 per diluted share, compared to the prior year fourth quarter of $0.19 per diluted share. Full-year 2024 non-GAAP net income was $0.48 per diluted share, compared to net income of $0.54 per diluted share for prior year 2023. Our non-GAAP operating margin, which excludes outside litigation spend and stock-based compensation expense, was 16.7% of revenue for the fourth quarter and 11.1% for full-year 2024, compared to 17.2% for the prior year fourth quarter and 15.3% for prior year 2023. Adjusted EBITDA, defined in our press release, was $20 million for the fourth quarter, or 17.5% of revenue, compared to the prior year fourth quarter of $21.3 million, or 19% of revenue. Full-year 2024 adjusted EBITDA was $53.1 million, or 12.4% of revenue, compared to adjusted EBITDA of $71.9 million, or 16.7% of revenue, for prior year 2023. Balance sheet. We ended the fourth quarter, December 31, 2024, with a cash balance and short-term investments of $88.8 million, compared to $125.3 million of cash and short-term investments for the prior year fourth quarter 2023. On a cash flow basis, for full-year 2024, operating cash flow decreased $38.8 million, compared to the prior year 2023 increase of $12.5 million. The results include litigation settlement expenses of $58.5 million and $2.7 million for full-year 2024 and 2023, respectively. Additionally, the effect of foreign currency translation was unfavorable by $8.2 million and $2.2 million for full-year 2024 and 2023, respectively. Deferred revenue as of December 31, 2024, was $281.2 million, compared to deferred revenue of $287 million for prior year 2023. Backlog, which includes the sum of billed deferred revenue and noncancelable future revenue, was $587.9 million as of December 31, 2024, compared to $606.8 million for prior year 2023. PeopleSoft update. As noted in our previous earnings call, we announced the wind-down of services for Oracle PeopleSoft products. We are now reassessing our exit from the PeopleSoft business in light of the recent litigation rulings and the continued demand in the market for our best-in-class offerings that extends beyond support. PeopleSoft revenue was $8 million and $32.9 million for the fourth quarter and full-year 2024, or 7% and 7.7% of total revenue, respectfully, while prior year revenue was $8.5 million and $36 million in the fourth quarter and full-year 2023, or 7.6% and 8.4%, respectively. Business outlook. The company is continuing to suspend guidance as to future financial results until there is more clarity around impacts from current litigation activity before the U.S. federal courts in the company's ongoing litigation with Oracle. For additional information and disclosures regarding the company's litigation with Oracle, please see our disclosures in the company's annual report on Form 10-K filed on February 27, 2025, with the U.S. Securities and Exchange Commission. This concludes our prepared remarks. Operator, we'll now take questions.